Drug discovery for Schistosoma mansoni : Bibliometric analysis and review of molecular targets and translational advances
Journal of Helminthology · 2026 · 100
DOI: 10.1017/s0022149x26102491 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Helminthology, online erschienen am 06.11.2026. Verfasst von L da Silva Lima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of Pernambuco, Brazil. Hauptthemen laut MEDLINE: Schistosoma mansoni, Drug Discovery, Schistosomicides, Schistosomiasis mansoni. Die Arbeit nennt 66 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
This review synthesizes recent advances in the discovery of schistosomicidal candidates, with particular emphasis on the medicinal chemistry of heterocyclic scaffolds and the identification of novel molecular targets. To this end, a contextual bibliometric assessment of the literature indexed in the Web of Science and Scopus databases was conducted, considering the chemical classes investigated, antiparasitic activity, parasite life stages evaluated, mechanistic evidence, biological targets explored, and the translational potential of the compounds. Overall, recent studies indicate that the discovery of new agents against Schistosoma mansoni still relies heavily on in vitro and in vivo phenotypic screening approaches. Nevertheless, target-based strategies have gained increasing prominence, particularly those focused on pathways essential for parasite survival, including epigenetic regulation, redox homeostasis, detoxification, nucleotide metabolism, tegument integrity, and neuromuscular function. Heterocyclic compounds, especially those containing nitrogen and sulphur atoms, have emerged as privileged scaffolds owing to their structural diversity, ease of chemical optimization, and ability to interact with multiple biological targets. The analysis also highlights the growing incorporation of computational chemistry, molecular modelling, and ADMET prediction tools in the prioritization of chemical series. Despite these advances, important gaps remain regarding the integration of structure–activity relationship (SAR) studies, target validation, elucidation of mechanisms of action, evaluation across different stages of the parasite life cycle, pharmaceutical formulation development, and pharmacokinetic and pharmacodynamic characterization. Strengthening these aspects is essential to translate promising compounds into clinically relevant candidates capable of overcoming the limitations of praziquantel-based therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Federal University of Pernambuco, Brazil.
ORCID-Profile: D S C Marques
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
da Silva Lima, L., de Oliveira Queiros, M. E., Miranda, J. F. D. O. M., Dos Santos, K. C. C., Marques, D. S. C., Cruz Filho, I. J. D., & Lima, M. D. C. A. D. (2026). Drug discovery for Schistosoma mansoni : Bibliometric analysis and review of molecular targets and translational advances. Journal of Helminthology, 100. https://doi.org/10.1017/s0022149x26102491
Vancouver
da Silva Lima L, de Oliveira Queiros ME, Miranda JFDOM, Dos Santos KCC, Marques DSC, Cruz Filho IJD, et al. Drug discovery for Schistosoma mansoni : Bibliometric analysis and review of molecular targets and translational advances. Journal of Helminthology. 2026;100. doi:10.1017/s0022149x26102491
BibTeX
@article{daSilvaLima2026,
author = {da Silva Lima, L and de Oliveira Queiros, M E and Miranda, J F D O M and Dos Santos, K C C and Marques, D S C and Cruz Filho, I J D and Lima, M D C A D},
title = {Drug discovery for Schistosoma mansoni : Bibliometric analysis and review of molecular targets and translational advances},
journal = {Journal of Helminthology},
year = {2026},
volume = {100},
doi = {10.1017/s0022149x26102491}
}
EUVIMED